RGT 3.85% 25.0¢ argent biopharma limited

5 March 2018In September 2017, MXC submitted its first...

  1. 2,484 Posts.
    lightbulb Created with Sketch. 80
    5 March 2018
    In September 2017, MXC submitted its first application to Australia’s Office of Drug Control (ODC) for its medicinal cannabis research cultivation licence for its collaborative research initiative with RMIT University. In recent months, RMIT and MXC have been actively working with the ODC to progress its licence application through the approval process. The Company and RMIT hope an Australian research cultivation licence will be granted in due course, and are actively engaging with the federal licensing body on any further requirements and next steps.

    30 April 2018
    MXC continues to progress with its first application to Australia’s Office of Drug Control (ODC), for a medical cannabis research licence. The receipt of this licence will facilitate and support the collaborative research work already underway with RMIT.

    rolleyes.png
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
25.0¢
Change
-0.010(3.85%)
Mkt cap ! $13.56M
Open High Low Value Volume
26.0¢ 26.0¢ 25.0¢ $11.58K 44.92K

Buyers (Bids)

No. Vol. Price($)
2 4408 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 86 1
View Market Depth
Last trade - 15.59pm 06/11/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.